成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

湖北瑞諾醫(yī)藥科技有限公司 公司信息

公司名稱: 湖北瑞諾醫(yī)藥科技有限公司
電話: -
電子郵件:3008058375@qq.com
國籍:中國
網(wǎng)址: www.is0513.com/showsupplierproductslist23141/0.htm
產(chǎn)品總數(shù):3001
13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

公司提供產(chǎn)品列表

Trimethoprim EP Impurity I (E-Isomer) 甲氧芐啶EP雜質(zhì)I 118791-61-0
Allopurinol Impurity 1 別嘌醇雜質(zhì)H 41621-10-7
Allopurinol Impurity 2 6-甲基-1氫-吡唑并[3,4-D]嘧啶-4(5H氫)酮 30129-57-8
Metronidazole EP Impurity C 甲硝唑雜質(zhì)C 5006-69-9
Metronidazole EP Impurity E 異甲硝唑 705-19-1
Metronidazole EP Impurity F O-羥乙基甲硝唑 16156-94-8
Azilsartan Impurity 25 阿齊沙坦雜質(zhì)5 183986-69-8
Azilsartan Impurity 26 阿齊沙坦雜質(zhì) 10 139481-40-6
Azilsartan Impurity 27 1-[(2'-(羥基脒基)[1,1-聯(lián)苯基]-4-基)甲基]-2-乙氧基-1H-苯并咪唑-7-甲酸甲酯 147403-65-4
Azilsartan Impurity 29 147404-12-4
Azilsartan Impurity 30 阿齊沙坦雜質(zhì)N 2244031-86-3
Azilsartan Impurity 36 1-[(2'-氰基聯(lián)苯-4-基)甲基]-2-乙氧基-1H-苯并咪唑-7-甲酸甲酯 139481-44-0
Glimepiride Impurity 1 格列美脲雜質(zhì)6 247098-17-5
Sorafenib EP Impurity A 4-(4-氨基苯氧基)-N-甲基-2-吡啶甲酰胺 284462-37-9
Sorafenib EP Impurity D Sorafenib impurity 14/Isopropyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate 2206827-14-5
Oseltamivir impurity 39 奧司他韋雜質(zhì)B(2-疊氮雜質(zhì)) 2125702-80-7
Oseltamivir impurity 41 (1R,5S,6R)-Ethyl 5-(Pentan-3-yloxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate 2413185-89-2
Oseltamivir impurity 43 奧司他韋雜質(zhì)17 2413185-88-1
Oseltamivir impurity 49 (3R,4S,5R)-4,5-二羥基-3-(戊烷-3-羥基)環(huán)己-1-烯-1-羧酸乙酯 2097777-49-4
Oseltamivir impurity 52 28547-24-2
Oseltamivir impurity 53 1070663-96-5
Olaparib Impurity 3 (3-氧代-1,3-二氫異苯并呋喃-1-基)膦酸二甲酯 61260-15-9
Olaparib Impurity 4 5-[(3.4-二氫-4-氧代-1-酞嗪基)甲基]-2-氟苯腈 1021298-68-9
Olaparib Impurity 6 2-氟-5-溴苯腈 179897-89-3
Olaparib Impurity 7 N-BOC-哌嗪 57260-71-6
Olaparib Impurity 8 環(huán)丙甲酸 1759-53-1
Olaparib Impurity 10 哌嗪二鹽酸鹽 142-64-3
Olaparib Impurity 15 1,1,3,3-四甲基脲 632-22-4
Butylphthalide Impurity 3 1(3H)-Isobenzofuranone, 5-bromo-3-hydroxy- 102126-71-6
Butylphthalide Impurity 5 6-溴-3-羥基異苯并呋喃-1(3氫)-酮 1225206-60-9
Butylphthalide Impurity 6 丁苯酞雜質(zhì)27 1225206-61-0
Butylphthalide Impurity 7 3,6-二溴異苯并呋喃-1(3H)-酮 40125-50-6
Butylphthalide Impurity 8 3,5-DIBROMO-1,3-DIHYDRO-2-BENZOFURAN-1-ONE 102126-70-5
Butylphthalide Impurity 9 3-butyl-5-bromo-1(3H)-isobenzofuranone 950681-35-3
Phloroglucinol Impurity 1 2,4,6-三甲氧基甲苯 14107-97-2
Phloroglucinol Impurity 72 Benzene, 1,3,5-trimethoxy-2-(methylthio)- 154389-62-5
Phloroglucinol Impurity 73 2,4,6,3',5'-PENTAMETHOXYBIPHENYL 84212-55-5
Valsartan Impurity 5 纈沙坦雜質(zhì)Ⅱ 1111177-30-0
Nedaplatin impurity 3 奈達(dá)鉑雜質(zhì)5 103436-60-8
Mesalazine EP Impurity S 美沙拉嗪EP雜質(zhì)S 1797983-23-3
Tryptophan EP Impurity A 粉色E 132685-02-0
Tryptophan EP Impurity B 色氨酸雜質(zhì)B(非對(duì)映體的混合物) 184955-21-3
Tryptophan EP Impurity C L-犬尿氨酸 2922-83-0
Tryptophan EP Impurity D 5-羥基-L-色氨酸 4350-09-8
Tryptophan EP Impurity E N'-甲?；?L-尿嘧啶 3978-11-8
Tryptophan EP Impurity H 2,3,4,9-四氫-1H-beta-咔啉-3-甲酸 6052-68-2
Tryptophan EP Impurity I 1 - 甲基-2,3,4,9 - 四氫-1H-Β-咔啉-3 - 羧酸鹽DATA 5470-37-1
Tryptophan EP Impurity J Tryptophan Impurity 3 164068-19-3
Tryptophan EP Impurity K L-色氨酸EP雜質(zhì)K 149724-31-2
Tryptophan EP Impurity L 色氨酸EP雜質(zhì)E 287170-99-4
Tryptophan Impurity 1 色氨酸EP雜質(zhì)G 236094-74-9
Tryptophan Impurity 2 DL-2,3-二氫-2-氧雜色氨酸 32999-55-6
Tofacitinib Impurity 17 托法替尼雜質(zhì) 2459302-77-1
Tofacitinib Impurity 22 Tofacitinib Impurity 29 1638499-35-0
Afatinib Impurity 4 N-(3-氯-4-氟苯基)-7-甲氧基-6-硝基喹唑啉-4-胺 179552-74-0
Afatinib Impurity 5 Afatinib Impurity JXH 2223677-60-7
Afatinib Impurity 6 阿法替尼雜質(zhì)18 2413212-25-4
Afatinib Impurity 7 4-氯-7-氟-6-硝基喹唑啉 162012-70-6
Afatinib Impurity 9 阿法替尼中間體 314771-88-5
Afatinib Impurity 11 P-[2-[[4-[(3-氯-4-氟苯基)氨基]-7-[[(3S)-四氫-3-呋喃基]氧基-6-喹唑啉基]氨基]-2-氧代乙基]膦酸二乙酯 618061-76-0
Afatinib Impurity 13 4-Hydroxy 4-Dedimethylamino Afatinib 2121530-37-6
Afatinib Impurity 14 Afatinib IMpurity SF 2223677-62-9
Afatinib Impurity 15 Afatinib IMpurity SCl 2223677-63-0
Afatinib Impurity 27 (S)-N1-(4-((3-氯-4-氟苯基)氨基)-7-(((四氫呋喃-3-基)氧基)喹唑啉-6-基)-N2,N2-二甲基草酰胺(阿法替尼雜質(zhì)) 2223677-66-3
Afatinib Impurity 28 阿法替尼雜質(zhì)DES-EJA 2223677-64-1
Afatinib Impurity 29 阿法替尼雜質(zhì)I 1637254-93-3
Afatinib Impurity 30 N-(3-氯-4-氟苯基)-7-乙氧基-6-硝基-4-喹唑啉胺 1360430-70-1
Afatinib Impurity 31 Afatinib Impurity 6 2413212-07-2
Nedaplatin impurity 2 奈達(dá)鉑雜質(zhì)4 20115-64-4
Doxofylline Impurity 13 茶堿雜質(zhì)23 23146-07-8
Doxofylline Impurity 12 羥丙茶堿 603-00-9
Doxofylline Impurity 10 多索茶堿雜質(zhì)02 180262-60-6
Doxofylline Impurity 7 多索茶堿雜質(zhì)7
Diclofenac EP Impurity E 2-吲哚酮 59-48-3
Erythromycin EP Impurity M Erythromycin EP Impurity M 616234-56-1
Olaparib Impurity 23 3-羥基異苯并呋喃-1(3H)-酮 16859-59-9
Olaparib Impurity 19 奧拉帕利雜質(zhì)31 458535-34-7
Butylphthalide Impurity 2 丁苯酞雜質(zhì) 199736-94-2
Butylphthalide Impurity 1 550-37-8
Paliperidone Impurity 4 5-氟-3-(4-哌啶基)-1,2-苯并異噁唑鹽酸鹽 84163-64-4
Azilsartan Impurity 21 阿齊沙坦雜質(zhì) 632322-61-3
Azilsartan Impurity 19 坎地沙坦酯中間體 139481-41-7
Azilsartan Impurity 18 阿齊沙坦雜質(zhì) (F) 147404-75-9
Azilsartan Medoxomil Potassium Salt 阿齊沙坦酯衍生物 863031-24-7
Azilsartan Medoxomil 阿奇沙坦酯 863031-21-4
Afatinib Impurity 32 馬來酸阿法替尼雜質(zhì)雜質(zhì)SM1-8-1 1269662-90-9
Tofacitinib Impurity 23 托法替尼雜質(zhì)166 1638499-36-1
Tryptophan EP Impurity F 色氨酸雜質(zhì) 145545-23-9
Butylphthalide Impurity 4 丁苯酞雜質(zhì)18 503822-00-2
Azilsartan Impurity 31 美阿沙坦鉀雜質(zhì)8 1993494-84-0
Azilsartan Impurity 40 阿齊沙坦雜質(zhì)15 147403-35-8
Brexpiprazole Impurity 12 依匹哌唑雜質(zhì)06 2137823-20-0
Brexpiprazole Impurity 16 7-(4-氯丁氧基)-2(1H)-喹啉酮 913613-82-8
Hydroxybupropion 羥基安非他酮 92264-81-8
Afatinib Impurity 18 2-氨基-4-氟苯甲酸 446-32-2
Afatinib Impurity 20 Afatinib IMpurity J 1456696-14-2
Afatinib Impurity 22 Afatinib impurity 9 2170273-17-1
Afatinib Impurity 23 7-[(R)-(四氫呋喃-3-基)氧基]-N-(3-氯-4-氟苯基)-6-氨基-4-氨基喹唑啉 402855-03-2
Afatinib Impurity 24 (S,E)-N-(4-((4-氯-3-氟苯基)氨基)-7-((四氫呋喃-3-基)氧基)喹唑啉-6-基)-4-(二甲基氨基)但是- 2-烯酰胺 (阿法替尼雜質(zhì)) 2475094-87-0
Afatinib Impurity 26 2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(methylamino)-, (2E)- 2413212-13-0
13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
Copyright 2007? ChemicalBook. All rights reserved.